Anna Lucsok - Zynex Chief Officer
| ZYXI Stock | USD 7.84 0.24 2.97% |
Insider
Anna Lucsok is Chief Officer of Zynex Inc
| Age | 39 |
| Phone | 303 703 4906 |
| Web | https://www.zynex.com |
Anna Lucsok Latest Insider Activity
Tracking and analyzing the buying and selling activities of Anna Lucsok against Zynex stock is an integral part of due diligence when investing in Zynex. Anna Lucsok insider activity provides valuable insight into whether Zynex is net buyers or sellers over its current business cycle. Note, Zynex insiders must abide by specific rules, including filing SEC forms every time they buy or sell Zynex'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Anna Lucsok few days ago Disposition of 7911 shares by Anna Lucsok of Zynex at 8.19 subject to Rule 16b-3 | ||
Anna Lucsok over two weeks ago Acquisition by Anna Lucsok of 2764 shares of Zynex subject to Rule 16b-3 | ||
Anna Lucsok over three months ago Acquisition by Anna Lucsok of 2764 shares of Zynex subject to Rule 16b-3 | ||
Anna Lucsok over three months ago Disposition of 2323 shares by Anna Lucsok of Zynex at 9.12 subject to Rule 16b-3 |
Zynex Management Efficiency
The company has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1023 %, meaning that it created $0.1023 on every $100 dollars invested by stockholders. Zynex's management efficiency ratios could be used to measure how well Zynex manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Napoleon Rutledge | McKesson | 53 | |
| Aster Angagaw | Owens Minor | 57 | |
| Kevin Emerson | McKesson | 51 | |
| Tammy Gomez | Owens Minor | N/A | |
| Kevin Barry | Patterson Companies | 47 | |
| Kenneth Smith | Owens Minor | 40 | |
| Nancy Avila | McKesson | 57 | |
| Ola Snow | Cardinal Health | 57 | |
| Graham Stanley | Henry Schein | N/A | |
| Alex CPA | Owens Minor | N/A | |
| N Coles | McKesson | 60 | |
| Deborah Weitzman | Cardinal Health | 60 | |
| Dean Scarborough | Cardinal Health | 64 | |
| Nicholas II | Owens Minor | 53 | |
| Linda Mantia | McKesson | 52 | |
| Andrea Frohning | Patterson Companies | 54 | |
| Tom Rodgers | McKesson | 49 | |
| Sheri Edison | Cardinal Health | 63 | |
| Tracy Faber | McKesson | 52 | |
| Kathleen Thompson | McKesson | N/A | |
| Holly Weiss | McKesson | N/A | |
Management Performance
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0399 |
Zynex Inc Leadership Team
Elected by the shareholders, the Zynex's board of directors comprises two types of representatives: Zynex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zynex. The board's role is to monitor Zynex's management team and ensure that shareholders' interests are well served. Zynex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zynex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Sandgaard, Chairman, CEO and President Principal Financial Officer and Principal Accounting Officer | ||
| Anna Lucsok, Chief Officer | ||
| Dave Anttila, Director HR | ||
| Daniel Moorhead, Chief Officer | ||
| Daniel CPA, Chief Officer | ||
| Steve Fox, Executive Sales | ||
| Chelle Burkleo, VP Sales | ||
| Donald Gregg, President Solutions | ||
| Joachim Sandgaard, Information Mang | ||
| Neil Friery, I Solutions |
Zynex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zynex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0399 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 294.36 M | ||||
| Shares Outstanding | 31.85 M | ||||
| Shares Owned By Insiders | 51.21 % | ||||
| Shares Owned By Institutions | 28.03 % | ||||
| Number Of Shares Shorted | 4.56 M | ||||
| Price To Earning | 28.60 X |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.